Back to Search Start Over

Polyfunctional KLRG-1 + CD57 + Senescent CD4 + T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients.

Authors :
Ramello MC
Núñez NG
Tosello Boari J
Bossio SN
Canale FP
Abrate C
Ponce N
Del Castillo A
Ledesma M
Viel S
Richer W
Sedlik C
Tiraboschi C
Muñoz M
Compagno D
Gruppi A
Acosta Rodríguez EV
Piaggio E
Montes CL
Source :
Frontiers in immunology [Front Immunol] 2021 Jul 27; Vol. 12, pp. 713132. Date of Electronic Publication: 2021 Jul 27 (Print Publication: 2021).
Publication Year :
2021

Abstract

Senescent T cells have been described during aging, chronic infections, and cancer; however, a comprehensive study of the phenotype, function, and transcriptional program of this T cell population in breast cancer (BC) patients is missing. Compared to healthy donors (HDs), BC patients exhibit an accumulation of KLRG-1 <superscript>+</superscript> CD57 <superscript>+</superscript> CD4 <superscript>+</superscript> and CD8 <superscript>+</superscript> T cells in peripheral blood. These T cells infiltrate tumors and tumor-draining lymph nodes. KLRG-1 <superscript>+</superscript> CD57 <superscript>+</superscript> CD4 <superscript>+</superscript> and CD8 <superscript>+</superscript> T cells from BC patients and HDs exhibit features of senescence, and despite their inhibitory receptor expression, they produce more effector cytokines and exhibit higher expression of Perforin, Granzyme B, and CD107a than non-senescent subsets. When compared to blood counterparts, tumor-infiltrating senescent CD4 <superscript>+</superscript> T cells show similar surface phenotype but reduced cytokine production. Transcriptional profiling of senescent CD4 <superscript>+</superscript> T cells from the peripheral blood of BC patients reveals enrichment in genes associated with NK or CD8 <superscript>+</superscript> -mediated cytotoxicity, TCR-mediated stimulation, and cell exhaustion compared to non-senescent T cells. Comparison of the transcriptional profile of senescent CD4 <superscript>+</superscript> T cells from peripheral blood of BC patients with those of HDs highlighted marked similarities but also relevant differences. Senescent CD4 <superscript>+</superscript> T cells from BC patients show enrichment in T-cell signaling, processes involved in DNA replication, p53 pathways, oncogene-induced senescence, among others compared to their counterparts in HDs. High gene expression of CD4, KLRG-1, and B3GAT1 (CD57), which correlates with increased overall survival for BC patients, underscores the usefulness of the evaluation of the frequency of senescent CD4 <superscript>+</superscript> T cells as a biomarker in the follow-up of patients.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Ramello, Núñez, Tosello Boari, Bossio, Canale, Abrate, Ponce, Del Castillo, Ledesma, Viel, Richer, Sedlik, Tiraboschi, Muñoz, Compagno, Gruppi, Acosta Rodríguez, Piaggio and Montes.)

Details

Language :
English
ISSN :
1664-3224
Volume :
12
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
34386013
Full Text :
https://doi.org/10.3389/fimmu.2021.713132